Device China DeviceChina - Home 中文版 zhuce yiduiyi Frequently Asked Questions 主页 English Language 注册参会 一对一约会 疑问解答






Medtronic plc Description

Medtronic plc ( has its principal executive offices in Ireland and continues to be operationally headquartered in Minneapolis. The company is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world. Medtronic has a comprehensive product portfolio, a diversified growth profile and broad geographic reach, with more than 85000 employees in more than 160 countries, reaching $27.7billion of revenue in FY14. Every 3 seconds, somewhere in the world, a person’s life is saved or improved by a Medtronic product or therapy.



About OrbiMed

Established in 1989, OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm. OrbiMed manages approximately USD$15 billion assets and has invested in approximately 300 private companies across a wide range of therapeutic categories and stages of development, over 100 of which have been either listed or acquired. OrbiMed has continued strong performance in public equity as well. OrbiMed Asia, with offices in Shanghai and Mumbai, has established one of the first pan-Asia healthcare-dedicated PE/VC funds.  With over USD$500 million under management, it has made investments in 31 companies. 



Frontline BioVentures


Frontline BioVentures is a premier venture capital firm based in China, with offices in Shanghai, Suzhou, and Hong Kong. We specialize in investment of innovative life sciences companies with business focuses on strategic areas promoted by the Chinese government for growth and development.


Our investment professionals have proven track records both domestically and overseas and have valuable resources and extensive experiences in nurturing and scaling venture startups. We are intimately familiar with the landscape of pharma, biotech and medtech industry in the country.



Founded in April 1997, Bank of Ningbo became the first city commercial bank listed on Shenzhen Stock Exchange on 19 July 2007.

By the end of first quarter of 2015, Bank of Ningbo has set up 12 branches outside Ningbo district in the cities of Shanghai, Hangzhou, Nanjing, Shenzhen, Suzhou, Wenzhou, Beijing, Wuxi, Jinhua, Shaoxing ,Taizhou and Jiaxing, with an overall 298 business networks. Bank of Ningbo also successfully set up Maxwealth Fund Management Co., Ltd. in November 2013, and obtained approval from regulators on the preparation of founding Maxwealth Financial Leasing Co., Ltd. in December 2014.

After 19 years’ growth since its establishment, along with the rapid growth of Chinese economy and the strong support from its customers and various parties, Bank of Ningbo has achieved substantial development. The Bank has developed into a public listed regional bank with total capital of over RMB 63 billion, total asset of over RMB 830 billion, net profit of RMB 6.5 billion and more than 10,000 employees, ranking among the World’s Top 200 banks.


LenoMedica Company is a medical device platform company established by several experienced experts in the medical device industry.  With the strong support from BioBAY(Suzhou Industrial Park), LenoMedica also cooperates with Legend Capital, Legend Star, Milestone Asset Management, and several VC and PE to undertake technology transfer from licensing or cross border investments and to focus on incubation and acceleration on startups.  This is a comprehensive platform covering from project selection, funding arrangement, company establishment, technology transfer, CFDA registration, marketing & sales, corporate governance, to M&A and IPO support.  We support our partners to carry out projects and warrant their investments in China.  LenoMedica also provides service to foreign customers and partners for imported product CFDA registration and marketing & sales in China afterwards. Current focus areas are diabetes, cardiovascular & neurovascular diseases, minimally invasive surgical products, in-vitro diagnostic products, and mobile medical/healthcare development.

To support Nation’s policy of promoting innovations and startups, LenoMedica and Milestone Asset Management have jointly established an angel fund “Suzhou CareStone Capital”.  That combines the advantages of LenoMedica’s execution experience in medical device industry and Milestone’s reputable capital planning and funding capability.  For both entrepreneurs and investors, by working together, this would increase the operating efficiency, avoid major mistakes, reduce the risk of failure, and increase the capital efficiency and return as well.  We currently invest and support Suzhou Bionex Medical, Shanghai Hanex Medical, Shanghai Maxus Medical, Zhejiang POCTech Corporation, Vita-Course Technologies, and several overseas medical device companies.


Sungent bioVENTURE was founded in Suzhou bioBAY on September 9th 2013 with a vision to be the best healthcare dedicated venture capital in China

Our team manages approximately USD 90 Million of the 1st phase of fund, with distinguished scientific, medical, investment and extensive professional experience and tacking records in the healthcare industry.

 The bioBAY, one of our leading investors own the best incubator and platform for life sciences start-ups in China, by levering the rich resources of bioBAY, we take more advantages and opportunities for investment continually.

 Up to now, the excellent results on return of investment have been achieved from the previously invested startups, which are encouraging us to be the best venture capital firm for healthcare in China.

 Dedicated for startups with growth potential, form biopharmaceuticals,medical devices, in-vitro diagnostics, to healthcare services, Sungent bioVENUTE is scouting the life sciences and healthcare industry for innovations that will bring people in better health and live longer.